drug
defibrotide sodium
Marketedupdated 3mo agoby $JAZZ Jazz Pharmaceuticals plc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 22, 2032
~5.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (5)
- Jun 22, 2032formulationUS 11085043
- Jun 22, 2032method-of-use (U-3301)US 11236328
- Jun 22, 2032formulationUS 11746348
- Jun 22, 2032formulationUS 12529052
- Jun 22, 2032formulationUS 12534722
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 14m ago
Found something off?
comments(0)
5-min edit window · permanent after that